38. Adjuvant Therapy of Ovarian Cancer With Radioactive Monoclonal Antibody

Nuclear Medicine Communications - United States
doi 10.1097/00006231-199204000-00040
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Monoclonal Antibody Therapy

AAOHN Journal
1987English

Reactivity of a Monoclonal Antibody With Human Ovarian Carcinoma.

Journal of Clinical Investigation
Medicine
1981English

Bismuth-213 Radioimmunotherapy With C595 Anti–MUC1 Monoclonal Antibody in an Ovarian Cancer Ascites Model

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2008English

Shikonin-Loaded Antibody-Armed Nanoparticles for Targeted Therapy of Ovarian Cancer

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2014English

Breast-Cancer Adjuvant Therapy With Zoledronic Acid

New England Journal of Medicine
Medicine
2012English

Complement-Mediated Mechanisms in Anti-Gd2 Monoclonal Antibody Therapy of Murine Metastatic Cancer

Cancer Research
Cancer ResearchOncology
2005English

Monoclonal Antibody Therapy for Non-Malignant Disease

Australian Prescriber
Pharmacology
2006English

Effect of Adjuvant Radioactive Iodine Therapy on Survival in Rare Oxyphilic Subtype of Thyroid Cancer (Hürthle Cell Carcinoma)

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2019English

Application of Anti-Pd-L1 Monoclonal Antibody Atezolizumab in Second Line Therapy of Common Urothelial Bladder Cancer

Effective Pharmacotherapy
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy